↓ Skip to main content

Chronic Genotype 3 Hepatitis E in Pregnant Woman Receiving Infliximab and Azathioprine

Overview of attention for article published in Emerging Infectious Diseases, May 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chronic Genotype 3 Hepatitis E in Pregnant Woman Receiving Infliximab and Azathioprine
Published in
Emerging Infectious Diseases, May 2018
DOI 10.3201/eid2405.171845
Pubmed ID
Authors

Caroline Charre, Christophe Ramière, Jérôme Dumortier, Florence Abravanel, Sébastien Lhomme, Rodica Gincul, Caroline Scholtès, C. Charre et al.

Abstract

Acute hepatitis E virus infection during pregnancy has a high fatality rate in developing countries. Little data are available on chronic infection in pregnant women. We report a case of chronic hepatitis E during treatment with infliximab and azathioprine, without adverse event during pregnancy and with spontaneous resolution after delivery.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 22%
Student > Ph. D. Student 3 13%
Other 2 9%
Student > Postgraduate 2 9%
Student > Bachelor 2 9%
Other 5 22%
Unknown 4 17%
Readers by discipline Count As %
Medicine and Dentistry 7 30%
Veterinary Science and Veterinary Medicine 2 9%
Biochemistry, Genetics and Molecular Biology 2 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Immunology and Microbiology 2 9%
Other 3 13%
Unknown 5 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2018.
All research outputs
#8,049,078
of 12,830,933 outputs
Outputs from Emerging Infectious Diseases
#5,295
of 6,475 outputs
Outputs of similar age
#162,888
of 270,764 outputs
Outputs of similar age from Emerging Infectious Diseases
#88
of 110 outputs
Altmetric has tracked 12,830,933 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,475 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.4. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,764 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.